Tryptophan

Tryptophan

SCHEMBL1458870

N[C@@H](CCC(=O)O)C(=O)O.N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O.N[C@@H](Cc1ccccc1)C(=O)O

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.74
KDM4E B2RXH2 3/20 0.74
MAPT P10636 3/20 0.74
MEN1 O00255 2/20 0.74
LMNA P02545 2/20 0.74
TSHR P16473 2/20 0.74
BLM P54132 2/20 0.74
PMP22 Q01453 2/20 0.74
MPO P05164 1/20 0.74
HIF1A Q16665 1/20 0.74
LTA4H P09960 2/20 0.55
HSP90AA1 P07900 1/20 0.55
HSP90AB1 P08238 1/20 0.55
PLA2G2A P14555 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.54
APAF1 O14727 1/20 0.53
POLB P06746 1/20 0.53
RECQL P46063 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
ALDH1A1 P00352 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dl-Tryptophan SCHEMBL22500891 1.00 KMT2A (0.74) KMT2AKDM4EMAPTMEN1LMNA
Dl-Tryptophan SCHEMBL27868840 0.97 KMT2A (0.70) KMT2AKDM4EMAPTMEN1LMNA
Dl-Tryptophan SCHEMBL27153460 0.95 KDM4E (0.82) KMT2AKDM4EMAPTMEN1LMNA
Tryptophan SCHEMBL6688035 0.95 KDM4E (0.82) KMT2AKDM4EMAPTMEN1LMNA
Dl-Tryptophan SCHEMBL8059982 0.95 KDM4E (0.82) KMT2AKDM4EMAPTMEN1LMNA
Tryptophan SCHEMBL4654771 0.92 KMT2A (0.73) KMT2AKDM4EMAPTMEN1LMNA
D-Tryptophan SCHEMBL11869971 0.92 KMT2A (0.89) KMT2AKDM4EMAPTMEN1LMNA
Tryptophan SCHEMBL120930 0.92 KMT2A (0.89) KMT2AKDM4EMAPTMEN1LMNA
Dl-Tryptophan SCHEMBL27641165 0.92 KMT2A (0.89) KMT2AKDM4EMAPTMEN1LMNA
Dl-Tryptophan SCHEMBL120929 0.92 KMT2A (0.89) KMT2AKDM4EMAPTMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2470216-A1 PEPTIDE CLEARING AGENTS Mologic Ltd (GB) 2012-07-04 EP disclosed
WO-2011036457-A1 PEPTIDE CLEARING AGENTS MOLOGIC LTD (GB) 2011-03-31 WO disclosed
EP-1667702-A2 PEPTIDES THAT INHIBIT COMPLEMENT ACTIVATION Baxter International Inc., Baxter Healthcare Corp. (US) 2006-06-14 EP disclosed
WO-2005023866-A2 PEPTIDES THAT INHIBIT COMPLEMENT ACTIVATION BAXTER INTERNATIONAL INC. (US) 2005-03-17 WO disclosed